Your session is about to expire
← Back to Search
Hearing Aid for Age-Related Hearing Loss (P-EARLHI Trial)
P-EARLHI Trial Summary
This trial studies the effects of hearing aid intervention in adults 55-75 with hearing loss, to improve their physical, social, and quality of life outcomes.
P-EARLHI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.P-EARLHI Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 55 and 75 years old and have little to no experience with hearing aids.I speak English or Spanish.
- Group 1: Hearing Intervention Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are elderly individuals aged 75 and above eligible for participation in this trial?
"The eligibility criteria for this trial stipulate that participants must be aged between 55 and 75."
Is there an opportunity for me to join this clinical research?
"Eligibility requirements for this study necessitate that candidates are between 55 and 75 years old, as well as have hearing impairment. Ideally, 40 participants will join the trial."
How many individuals have enrolled in this clinical study thus far?
"Affirmative. Clinicaltrials.gov records show that this trial, which was first advertised on June 19th 2023, is presently recruiting patients. 40 participants are needed from a single medical centre."
Are any additional participants being admitted into this trial?
"Affirmative. Clinicaltrials.gov confirms that this trial, first posted on June 19th 2023, is actively looking for 40 patients from one centre to join in the research. The data was last updated on July 24th 2023."
Share this study with friends
Copy Link
Messenger